News

One in six patients with heart failure with reduced ejection fraction (HFrEF) develops worsening HF within 18 months of an initial diagnosis, according to research published in the Journal of the American College of Cardiology, and these declining patients aren’t receiving the right standard of care.

Women with type 2 diabetes are more likely than those without to develop more advanced, aggressive forms of breast cancer, Reuters reported of a study Feb. 27.

A recently published mouse study may offer clues about why premenopausal women are less prone than men to “nondipping hypertension,” a condition in which blood pressure doesn’t drop its normal 10 to 20 percent at night.

With the American College of Cardiology’s annual congress fast approaching in March and two new JACC medical journals slated to launch later this year, the ACC is lining up its priorities for 2019.

The global market for transcatheter treatment of the mitral and aortic valves is expected to double over the next five years, according to a new report from BCC Research. The industry analysis projects an increase from $4 billion in 2018 to $8 billion in 2023, at a compound annual growth rate (CAGR) of 14.8 percent.

A small-scale study out of Germany has concluded thrombectomy—an already proven treatment for large intracranial vessel occlusions in adults—is also safe in children.

A new matchstick-sized continuous glucose monitor (CGM) can be implanted under the skin, allowing diabetics to track their blood sugar without the inconvenience of finger pricks and patches, according to a CBS report.

Two of Medtronic’s drug-eluting stents (DES)—the Resolute Onyx and the Resolute Integrity—have been granted FDA approval to treat coronary artery disease patients with chronic total occlusion (CTO), the company announced Feb. 26.

Employees at Baylor St. Luke’s Medical Center in Houston made 122 mistakes in the labeling of blood over a four-month period, according to a federal review prompted by the December death of a 75-year-old woman who received the wrong blood type and died after suffering repeated bouts of cardiac arrest.

Electrocardiograms (ECG) acquired using a chest strap could be a quality alternative to traditional ECGs when used to diagnose atrial fibrillation (AF), researchers reported in the American Journal of Cardiology.

Physician bias against overweight and obese patients is not only prevalent in today’s medical landscape, according to an analysis published in JAMA Feb. 20—it could also be overshadowing quality care and driving some of those patients further from the doctor’s office.

ACC.19 will feature 36 late-breaking clinical trials and clinical research studies, starting with the Apple Heart Study’s findings on the ability of a smartwatch to help identify atrial fibrillation. That question is just one of many the conference will address, says ACC.19 Program Chair Andrew Kates, MD, professor of medicine and director of the cardiology fellowship program at Washington University School of Medicine in St. Louis. During a conversation with Cardiovascular Business, Kates predicted trial highlights and previewed some ACC.19 program innovations.